Clinical Trial Detail

NCT ID NCT01717053
Title Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

prostate cancer

Therapies

Leuprolide

Abiraterone

Prednisone

Goserelin

Age Groups: adult

No variant requirements are available.